Your browser doesn't support javascript.
loading
CIMT 2024: Report on the 21st Annual Meeting of the Association for Cancer Immunotherapy.
Ahrberg, Yasemin; Dallmann, Julia; Freitag, Janina; Hassan, Abdulrizak; Jung, Christina; Kiefer, Johanna; Muralidharan, Anindhita Meena; Peter, Matthias; Beck, Jan D.
Afiliación
  • Ahrberg Y; TRON-Translational Oncology, University Medical Center of Johannes Gutenberg University Mainz gGmbH, Mainz, Germany.
  • Dallmann J; BioNTech SE, Mainz, Germany.
  • Freitag J; TRON-Translational Oncology, University Medical Center of Johannes Gutenberg University Mainz gGmbH, Mainz, Germany.
  • Hassan A; BioNTech SE, Mainz, Germany.
  • Jung C; BioNTech Cell & Gene Therapies GmbH, Mainz, Germany.
  • Kiefer J; BioNTech SE, Mainz, Germany.
  • Muralidharan AM; TRON-Translational Oncology, University Medical Center of Johannes Gutenberg University Mainz gGmbH, Mainz, Germany.
  • Peter M; TRON-Translational Oncology, University Medical Center of Johannes Gutenberg University Mainz gGmbH, Mainz, Germany.
  • Beck JD; BioNTech SE, Mainz, Germany.
Hum Vaccin Immunother ; 20(1): 2381925, 2024 Dec 31.
Article en En | MEDLINE | ID: mdl-39043196
ABSTRACT
The 21st Association for Cancer Immunotherapy (CIMT) Annual Meeting took place from May 15th to May 17th in Mainz, Germany, and was attended by a total of 855 academic and clinical professionals hailing from 33 different countries. The conference served as a platform for these experts to convene and discuss the latest breakthroughs in cancer immunology and immunotherapy research. Dedicated sessions covering advancements in artificial intelligence tools for cancer immunotherapy research, as well as the landscape of cancer care and cancer immunotherapy trials on the African continent, prompted lively and informative discussions among the attendees. This report aims to provide an overview of the most noteworthy highlights and key takeaways from CIMT2024.
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inmunoterapia / Neoplasias Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Hum Vaccin Immunother Año: 2024 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inmunoterapia / Neoplasias Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Hum Vaccin Immunother Año: 2024 Tipo del documento: Article País de afiliación: Alemania